India to Dominican Republic: Glucosamine Export Trade Route

The India to Dominican Republic Glucosamine corridor is one of India's established pharmaceutical export routes, with 7 shipments documented worth a combined $278.2K USD. The route is dominated by VEROS HEALTHCARE PRIVATE LIMITED, which alone accounts for roughly 90% of all export value, reflecting the consolidated nature of India's glucosamine manufacturing sector.

Across 2 active suppliers, the average shipment value stands at $39.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 70% of all shipments, consistent with glucosamine's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 33 days port-to-port. The route has recorded an annual growth rate of 24.7%, placing it at rank #10 among India's top glucosamine export destinations globally.

On the import side, key buyers of Indian glucosamine in Dominican Republic include SUED FARGESA S R L, SUED & FARGESA SRL, SALDENT INTERNACIONAL S.R.L.,. SUED FARGESA S R L is the single largest importer with 2 shipments valued at $140.8K USD.

India's glucosamine exports to Dominican Republic are driven primarily by a handful of large-scale manufacturers. VEROS HEALTHCARE PRIVATE LIMITED with 6 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in Dominican Republic benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — VEROS HEALTHCARE PRIVATE LIMITED, CAPLIN POINT LABORATORIES LIMITED — together account for 100% of total trade value on this route. The average shipment value of $39.7K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as meloxicam+glucosamine sulfate granules for oral solution (15mg + 1500mg) gluxicam (meloxicam 15mg + sulfato de and doloartrisar (glucosamine 500mg +chondrotin 400mg + meloxicam15mg) soft gel capsule batch no: s2421148, suggesting that buyers in Dominican Republic tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, SUED FARGESA S R L is the largest importer with 2 shipments worth $140.8K USD — representing 51% of all glucosamine imports from India on this route.